Nasal immune adjuvant protects mice against respiratory viruses for months
The COVID-19 pandemic showed the challenges of protecting populations when a new respiratory virus emerges.
Read original article on The Medical News →Related news
-
Sauce placement shapes diners’ perceptions of food healthiness
United Kingdom
-
Prenatal training may reduce postpartum depression risk in women with previous births
United Kingdom
-
New project aims to test a protein-based therapy for Fragile X syndrome
United Kingdom
-
Routine blood test may offer clues to future dementia risk
United Kingdom
-
Friends of BrainHealth grants advance dementia prevention and brain health research
United Kingdom
-
Study finds both the liver and brain drive distinct symptoms of rare genetic epilepsy
United Kingdom
-
Researchers develop trauma-informed AI model to support online student persistence
United Kingdom
-
Study identifies a link between specific brain circuits and anxiety in adolescents
United Kingdom